The intricate mechanisms of the nervous system continue to be a focal point of scientific investigation, with a particular emphasis on understanding and combating neurodegenerative conditions. Within this research domain, compounds that exhibit neuroprotective properties are of immense value. Cbz-L-Glutamic acid 1-benzyl ester, identified by its CAS number 3705-42-8, is emerging as a significant player in this field. Its utility as a potential neuroprotective agent makes it a sought-after compound for laboratories engaged in advanced neurological studies. As a specialized amino acid derivative, Cbz-L-Glutamic acid 1-benzyl ester possesses characteristics that facilitate its use in complex biological and chemical experiments. Its typical presentation as a white solid and its defined solubility in solvents like methanol and DMSO are important parameters for researchers. The compound's primary function as a potential neuroprotective agent means it can be instrumental in developing strategies to safeguard neurons from various forms of damage, including excitotoxicity and oxidative stress. For scientists and researchers looking to buy Cbz-L-Glutamic acid 1-benzyl ester, ensuring the quality and purity of the source is paramount. NINGBO INNO PHARMCHEM CO.,LTD., a distinguished pharmaceutical intermediates supplier in China, offers this essential chemical. Our role as a manufacturer means we are dedicated to maintaining high standards throughout the production process, ensuring that our N-Benzyloxycarbonyl-L-glutamic acid 1-benzyl ester meets the demanding requirements of pharmaceutical research. By procuring this compound, researchers can explore its efficacy in various experimental models, contributing to the broader understanding of neurological health and disease. The accessibility of Cbz-L-Glutamic acid 1-benzyl ester CAS 3705-42-8 from reliable sources like NINGBO INNO PHARMCHEM CO.,LTD. streamlines the research process, allowing scientists to focus on their critical work. Partner with us for your fine chemical needs and contribute to the advancement of neuroprotective therapies.